New drug BAT1308 tested for safety in advanced cancer patients
NCT ID NCT05155722
First seen Jan 11, 2026 · Last updated Jun 14, 2026 · Updated 22 times
Summary
This early-stage study tested a new drug called BAT1308 in 59 adults with advanced solid tumors that did not respond to standard treatments. The main goal was to find a safe dose and check for side effects. Researchers also looked at how the drug moves through the body. This is a safety study, not a cure, and aims to control the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Henan Tumor Hospital
Zhengzhou, Henan, 450003, China
Conditions
Explore the condition pages connected to this study.